Journal
JOURNAL OF CYSTIC FIBROSIS
Volume 15, Issue 3, Pages 309-312Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jcf.2016.04.003
Keywords
Cystic fibrosis; CFTR gene; Newborn screening; Complex allele; False positive
Categories
Funding
- CHU de Montpellier
- French association Vaincre La Mucoviscidose
Ask authors/readers for more resources
The detection of two frequent CFTR disease-causing variations in the context of a newborn screening program (NBS) usually leads to the diagnosis of cystic fibrosis (CF) and a relevant genetic counseling in the family. In the present study, CF-causing variants p.Phe508del (F508del) and c.3140-26 A > G (3272-26 A > G) were identified on a neonate with positive ImmunoReactive Trypsinogen test by the Elucigene (TM) CF30 kit. The CF diagnosis initially suggested, despite three inconclusive Sweat Chloride Tests (SCT), was finally ruled out after the familial segregation study combined with a negative SCT. Haplotype studies, based on the comparison of 80 p.Phe508del haplotypes, suggested a probable de novo occurrence of c.3140-26 A > G on the p.Phe508del ancestral allele in this family. This false positive case emphasizes the importance of SCT in the NBS strategy. Moreover, it raises the need for familial segregation studies in CF and in overall molecular diagnosis strategy of autosomal recessive diseases. (C) 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available